Search Results 291-300 of 16969 for monoclonal antibody
Monoclonal antibodies, such as varlilumab and nivolumab, may work by stimulating the immune system to attack cancer tumor cells. A Study to Evaluate the Use ...
Trastuzumab-strf is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread ...
... monoclonal antibody, to decrease dose-reducing toxicities. In the phase 1 trial, researchers observed reduced markers of toxicities and no new safety issues ...
Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...
A blood test might show nontypical antibodies that interrupt the receptor sites where nerves signal your muscles to move. ... Monoclonal antibody. Rituximab ( ...
Monoclonal antibody therapies in multiple myeloma. Preclinical models of Waldenstrom macroglobulinemia. Significance to Patient Care. Dr. Chanan-Khan is ...
Vedolizumab injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is a monoclonal antibody that works on ...
These previous treatments include a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. This medicine is available only ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.